Top news of the week: 17.01.2023.
The State of Biotech Recap
At the State of Biotech two-day, free virtual event hosted by GEN, thought leaders discussed the biotech industry’s current status and future possibilities.
Biomanufacturing Startup Visolis Has Raised $8 Million To Make Carbon-Negative Materials
Visolis is on a mission to capture large ingredients markets with their sustainable platform chemicals made from carbon-negative feedstocks.
MassBio’s 2022 Massachusetts Biopharma Funding Report Shows Strong Industry Investment Despite Market Reset and Ongoing Economic Uncertainty
CAMBRIDGE, MA—January 12, 2023—The Massachusetts Biotechnology Council (MassBio®) today released its 2022 Massachusetts Biopharma Funding Report that showed another strong year for ...
Baltimore closed 2022 with an uptick in investment. But the tally may be incomplete
The Q4 increase, while not enough to make 2022 surpass 2021's banner highs, still appeared to buck a nationwide trend of decline and normalization, as reported by PitchBook-NCVA. That ...
Seven Biopharma Trends to Watch in 2023
Key trends include fewer and slower financings, a surge of decisive data readouts for cancer vaccines, and further development of mRNA, cell, and gene therapies.
5 ways biotech can help support patients and their communities
How would you feel about 'JPM Week' moving to Miami? George Yancopoulos isn't apologizing Regeneron entered JPM with negative headlines, partly because sales of its best-selling …
How China’s Leading Female Healthcare Investor Backs Billion-Dollar Biotech Companies
As managing partner of Qiming Venture Partners, Nisa Leung has invested in over 30 of China’s healthcare giants. Underlying her prolific track record is her goal to solve as many incurable ...
Debt bomb, biotech bump and a bond rally: 2023 money predictions
If there was only one word to sum up 2022, "unpredictable" might be the most accurate.